Durable remissions in TCF3-HLF positive acute lymphoblastic leukemia with blinatumomab and stem cell transplantation
TCF3-HLF -positive leukemia represents a rare subtype of childhood acute lymphoblastic leukemia (ALL), characterized by a high rate of treatment failure despite treatment intensification and allogeneic stem cell transplantation (SCT). Given the high and homogeneous expression of CD19 on blast cells
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2019
|
| In: |
Haematologica
Year: 2019, Volume: 104, Issue: 6 |
| ISSN: | 1592-8721 |
| DOI: | 10.3324/haematol.2018.210104 |
| Online Access: | Verlag, Volltext: https://doi.org/10.3324/haematol.2018.210104 Verlag: http://www.haematologica.org/content/104/6/e244 
|
| Author Notes: | by Brice Mouttet, Luciana Vinti, Philip Ancliff, Nicole Bodmer, Benoît Brethon, Gunnar Cario, Christiane Chen-Santel, Sarah Elitzur, Volkan Hazar, Joachim Kunz, Anja Möricke, Jerry Stein, Ajay Vora, Yöntem Yaman, Martin Schrappe, Sema Anak, André Baruche, Franco Locatelli, Arend von Stackelberg, Martin Stanulla, and Jean-Pierre Bourquin |
| Summary: | TCF3-HLF -positive leukemia represents a rare subtype of childhood acute lymphoblastic leukemia (ALL), characterized by a high rate of treatment failure despite treatment intensification and allogeneic stem cell transplantation (SCT). Given the high and homogeneous expression of CD19 on blast cells |
|---|---|
| Item Description: | Published ahead of print on February 14, 2019 Gesehen am 07.10.2019 |
| Physical Description: | Online Resource |
| ISSN: | 1592-8721 |
| DOI: | 10.3324/haematol.2018.210104 |